Nuburu is trading 10% down at $0.04, amid continued uncertainty over OTC trading following the 1-for-40 reverse split.
- No new September 4, 2026 company-specific announcement explicitly explains the decline.
- Uncertainty also surrounds the temporary trading symbol and pending NYSE American appeal; Nuburu warned continued OTC trading could negatively affect liquidity and market price.
- Broader markets are nearly flat, so market-wide sentiment does not clearly explain the drop.